Lipella Pharmaceuticals Inc (LIPO)
NASDAQ
The current LIPO market cap is 3.87M. The company's latest EPS is USD -3.8208 and P/E is -0.87.
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 962k | 259k | 184k | 450k |
Operating Income | -57k | -1.92M | -2.59M | -4.75M |
Net Income | -62k | -1.87M | -2.6M | -4.62M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 955k | 2.01M | 5.95M | 3.58M |
Total Liabilities | 492k | 589k | 1.27M | 433k |
Total Equity | 463k | 1.42M | 4.68M | 3.14M |
Market Cap | 3.87M |
Price to Earnings Ratio | -0.87 |
Price to Sales Ratio | 8.92 |
Price to Cash Ratio | 1.22 |
Price to Book Ratio | 1.28 |
Dividend Yield | - |
Shares Outstanding | 1.21M |
Average Volume (1 week) | 120.03k |
Average Volume (1 Month) | 169.84k |
52 Week Change | -58.53% |
52 Week High | 12.00 |
52 Week Low | 2.21 |
Spread (Intraday) | 0.2 (5.88%) |
Company Name | Lipella Pharmaceuticals Inc |
Address |
108 west 13th street wilmington, delaware 19801 |
Website | https://www.lipella.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.